Duprey Lauren Rusckowski

SEC Form 4 insider

Chief Transformation Officer · TAKEDA PHARMACEUTICAL CO LTD ($TAK)

2 theses · first seen Aug 13, 2026

Window	Theses	Resolved	Wins	Win rate	Avg return	Median return
1d	2	2	2	100%	-0.2%	-0.2%
3d	2	2	0	0%	+1.2%	+1.2%
1w	2	2	0	0%	+3.3%	+3.3%
1m	2	2	0	0%	+4.4%	+4.4%
3m	1	1	0	0%	+19.9%	+19.9%
6m	0	0	0	—	—	—
1y	0	0	0	—	—	—

Past performance does not predict future results. Informational only, not investment advice.

Thesis history

$TAKSEC Form 4bearish

Duprey Lauren Rusckowski · Chief Transformation Officer at TAKEDA PHARMACEUTICAL CO LTD · 60d ago1 prior · 0% at 3mo

Sold 34,535 @ $18.54 avg · $640,279 · 2026-09-14

Form 4: Duprey Lauren Rusckowski sold TAK

Duprey Lauren Rusckowski (Chief Transformation Officer at TAKEDA PHARMACEUTICAL CO LTD) reported an open-market sale of 34,535 shares of TAK at an average $18.54, roughly $640,279, in a Form 4 filed 2026-09-15.

At post $18.70Now $21.12+12.9% since postedas of Nov 12, 4:31 PM ET

1d-0.3%

3d+1.1%

1w+1.3%

1m+4.0%

3m—

6m—

1y—

View filing on SEC.gov →

$TAKSEC Form 4bearish

Duprey Lauren Rusckowski · Chief Transformation Officer at TAKEDA PHARMACEUTICAL CO LTD · 94d ago1 prior · 0% at 3mo

Sold 47,586 @ $17.10 avg · $813,721 · 2026-08-10

Form 4: Duprey Lauren Rusckowski sold TAK

Duprey Lauren Rusckowski (Chief Transformation Officer at TAKEDA PHARMACEUTICAL CO LTD) reported an open-market sale of 47,586 shares of TAK at an average $17.10, roughly $813,721, in a Form 4 filed 2026-08-12.

At post $17.41Now $21.12+21.3% since postedas of Nov 12, 4:31 PM ET

1d-0.1%

3d+1.3%

1w+5.3%

1m+4.9%

3m+19.9%

6m—

1y—

View filing on SEC.gov →

End of results.